4-[(Dimethylamino)iminomethyl]benzoic Acid HCl: A Critical Intermediate for API Manufacturers
In the competitive pharmaceutical industry, the efficiency and reliability of the supply chain for key intermediates are critical for success. 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, known by its CAS No. 210963-78-3, stands out as a significant pharmaceutical intermediate, valued for its role in the synthesis of various APIs. This article explores its importance for API manufacturers and the advantages of sourcing it from experienced chemical producers.
Product Overview: 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl
This chemical compound, with the molecular formula C10H13ClN2O2 and a molecular weight of 228.67542, typically appears as a white powder. It is recognized as a fine chemical intermediate, essential for complex organic synthesis processes within the pharmaceutical sector. Its specific structural characteristics make it a sought-after component for creating sophisticated APIs, thereby impacting the development of effective medications.
The Manufacturer's Role in Quality and Supply
For API manufacturers, the quality of intermediates directly translates to the quality of the final drug product. Therefore, sourcing 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl from a reputable manufacturer is paramount. Companies in China are often at the forefront of producing such intermediates, leveraging advanced manufacturing technologies and rigorous quality control protocols. A reliable manufacturer ensures that the product meets strict purity standards, has a well-defined impurity profile, and is available in consistent batches. This reliability is crucial for uninterrupted production schedules and regulatory compliance.
Strategic Sourcing and Purchasing Insights
When considering where to buy 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, API manufacturers typically look for suppliers who offer not only competitive pricing but also a robust support system. This includes providing comprehensive product documentation (CoA, MSDS) and demonstrating a stable supply chain. Building a relationship with a trusted manufacturer or supplier in China can lead to significant advantages, including cost efficiencies and enhanced product traceability. We are dedicated to serving the needs of API manufacturers by providing this vital intermediate with guaranteed quality and reliable delivery.
Conclusion
4-[(Dimethylamino)iminomethyl]benzoic Acid HCl (CAS 210963-78-3) is a cornerstone intermediate for the pharmaceutical industry. Its consistent demand underscores the importance of selecting suppliers who prioritize quality, offer competitive pricing, and ensure a reliable supply chain. By partnering with experienced manufacturers, API producers can secure the materials needed to drive pharmaceutical innovation forward.
Perspectives & Insights
Agile Reader One
“By partnering with experienced manufacturers, API producers can secure the materials needed to drive pharmaceutical innovation forward.”
Logic Vision Labs
“In the competitive pharmaceutical industry, the efficiency and reliability of the supply chain for key intermediates are critical for success.”
Molecule Origin 88
“210963-78-3, stands out as a significant pharmaceutical intermediate, valued for its role in the synthesis of various APIs.”